BioSymetrics vs Caris Life Sciences
BioSymetrics vs Caris Life Sciences, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioSymetrics is on 63/100 and Caris Life Sciences on 59/100.
Where each one leads
BioSymetrics
- our overall score: 63/100 against 59/100
Caris Life Sciences
- domain rating: 63/100 against 30/100
- headcount: 1,659 against 14
- funding raised: $700M against $6.6M
- LinkedIn following: 77,698 against 3,571
At a glance
| Measure | BioSymetrics | Caris Life Sciences |
|---|---|---|
| What it is | Phenomics-driven AI company translating disease biology into precision medicine discoveries. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, HealthTech, Drug Discovery, Genomics | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2008 |
| Headquarters | Boston, United States | Irving, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BioSymetrics | Caris Life Sciences |
|---|---|---|
| Employees | 14 | 1,659 |
| Headcount growthLast 12 months | +139.3% | Not published |
| Total funding | $6.6M | $700M |
| Latest round | Seed | Series D |
| Valuation | Not published | $7.8B |
| LinkedIn followers | 3,571 | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioSymetrics | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 59/100 |
| Traction | Not published | 60/100 |
| Team | 96/100 | Not published |
| Search visibility | 64/100 | 22/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 30/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioSymetrics | Caris Life Sciences |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Not detected | WordPress |
| Analytics | Not detected | Google Tag Manager |
| Open source | Yes | No |
BioSymetrics vs Caris Life Sciences: common questions
Which is better, BioSymetrics or Caris Life Sciences?
On our 0-100 score BioSymetrics rates higher (63/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do BioSymetrics and Caris Life Sciences compare on the numbers?
BioSymetrics leads on our overall score (63/100 against 59/100). Caris Life Sciences leads on domain rating (63/100 against 30/100), headcount (1,659 against 14), funding raised ($700M against $6.6M), LinkedIn following (77,698 against 3,571).
Read the full BioSymetrics review and pricing or the Caris Life Sciences review and pricing. You can also browse other BioSymetrics alternatives we track.